Download PDF
Horm Metab Res 2005; 37: 61-68
DOI: 10.1055/s-2005-861398
Review
© Georg Thieme Verlag KG Stuttgart · New York

Pathogenesis of Foot Ulcers and the Need for Offloading

H.  M.  Rathur1 , A.  J.  M.  Boulton1
  • 1 Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, UK
Further Information

Publication History

Received 22 December 2004

Accepted after Revision 21 February 2005

Publication Date:
25 May 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Diabetic foot ulceration represents a major medical, social and economic problem all over the world. While more than 5 % of diabetic patients have a history of foot ulceration, the cumulative lifetime incidence may be as high as 15 %. Ethnic differences exist in both ulcer and amputation incidences. Foot ulceration results from the interaction of several contributory factors, the most important of which is neuropathy. The use of the total-contact cast is demonstrated in the treatment of plantar neuropathic ulcers. Histological evidence suggests that pressure relief results in chronic foot ulcers changing their morphological appearance by displaying some features of an acute wound. Thus, repetitive stresses on the insensate foot appear to play a major role in maintaining ulcer chronicity. It is hoped that research activity in foot disease will ultimately result in fewer ulcers and less amputation in diabetes.

Key words

Diabetic foot - Diabetic neuropathy - Foot ulcer - Amputation - Total Contact Cast (TCC)

References

  • 1 Wild S, Roglie G, Green A, King H. Global prevalence of diabetes: estimates for 2000 and projections for 2030.  Diabetes Care;. 2004;  27 1047-1053
    CrossrefPubMedGoogle Scholar
  • 2 Boyko E J, Ahroni J H, Smith D G, Davignon D. Increased mortality associated with diabetic foot ulcer.  Diabetic Med. 1996;  13 967-972
    CrossrefPubMedGoogle Scholar
  • 3 Krentz A J, Acheson P, Basu A, Kilvert A, Wright A D, Natrass M. Morbidity and mortality associated with diabetic foot disease: a 12-month prospective survey of hospital admissions in a single UK centre.  Foot. 1997;  7 144-147
    CrossrefPubMedGoogle Scholar
  • 4 Jude E B, Boulton A JM. End stage complications of diabetic neuropathy.  Diabetes Reviews. 1999;  7 395-410
    PubMedGoogle Scholar
  • 5 Shaw J E, Zimmet P Z. The epidemiology of diabetic neuropathy.  Diabetes Rev. 1999;  6 245-252
    PubMedGoogle Scholar
  • 6 Williams D RR, Airey M. The size of the problem: epidemiological and economical aspects of the diabetic foot. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes; 3rd edition. Chichester; Wiley 2000: 3-17
    Google Scholar
  • 7 Reiber G E, Ledoux W R. Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. In: Williams R, Herman W, Kinmonth AL, Wareham NJ (eds) The evidence base for diabetes care. Chichester; Wiley 2002: 641-665
    Google Scholar
  • 8 Carrington A L, Abbott C A, Griffiths J, Jackson N, van Ross E RE, Boulton A JM. A foot care programme for diabetic unilateral amputees.  Diabetes Care. 2001;  24 216-221
    CrossrefPubMedGoogle Scholar
  • 9 Kumar S, Ashe H, Fernando D JS, Tsigos C, Young R J, Boulton A JM. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study.  Diabetic Med. 1994;  11 480-484
    CrossrefPubMedGoogle Scholar
  • 10 Abbott C A, Carrington A L, Ashe H. et al . The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.  Diabetic Med. 2002;  20 377-384
    PubMedGoogle Scholar
  • 11 Muller I S, de Graum W J, van Gerwen W H. et al . Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care.  Diabetes Care. 2002;  25 570-574
    PubMedGoogle Scholar
  • 12 Lavery L A, Armstrong D G, Wunderlich R P, Tredwell J, Boulton A JM. Diabetic Foot Syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-hispanic whites from a diabetes management cohort.  Diabetes Care. 2003;  26 1435-1438
    CrossrefPubMedGoogle Scholar
  • 13 Humphrey A RG, Thomas K, Dowse G K, Zimmet P Z. Diabetes and non-traumatic lower extremity amputations. Incidence, risk factors and prevention: a 12 year follow-up study in Nauru.  Diabetes Care. 1996;  19 710-714
    PubMedGoogle Scholar
  • 14 Behhadj M A. La pace du pied diabetique [in French].  Diabete Metab. 1998;  24 [Supp] LXVII
    PubMedGoogle Scholar
  • 15 Pendsey S. Epidemiological aspects of the diabetic foot.  J Diabetes Develop Countries. 1998;  2 37-38
    PubMedGoogle Scholar
  • 16 Young M A, Veves A, Breddy J L, Boulton A JM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study.  Diabetes Care. 1994;  17 557-560
    CrossrefPubMedGoogle Scholar
  • 17 Abbott C A, Vileikyte L, Williamson S, Carrington A L, Boulton A JM. Multicentre study of the incidence of and predictive factors for diabetic neuropathic foot ulcers.  Diabetes Care. 1998;  21 1071-1075
    CrossrefPubMedGoogle Scholar
  • 18 Larsson J, Apelqvist J, Agardh G D, Stenstrom A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?.  Diabetic Med. 1995;  12 770-776
    CrossrefPubMedGoogle Scholar
  • 19 Trautner C, Haastert B, Spraul M, Giani C, Berger M. Unchanged incidence of lower limb amputations in a German city 1990 - 1998.  Diabetes Care. 2001;  24 855-859
    CrossrefPubMedGoogle Scholar
  • 20 Trautner C, Haastert B, Giani C, Berger M. Amputations and diabetes: a case control study.  Diabetic Med. 2002;  19 35-40
    CrossrefPubMedGoogle Scholar
  • 21 No authors listed. An audit of amputations in a rural health district.  Practical Diabetes Int. 1997;  14 174-178
    PubMedGoogle Scholar
  • 22 Toledano H, Young M J, Veves A, Boulton A JM. Why do Asian diabetic patients have fewer foot ulcers than Caucasians.  Diabetic Med. 1993;  [Suppl 1] 539
    PubMedGoogle Scholar
  • 23 Chaturvedi N, Abbot C A, Whalley A, Leggetter S Y, Boulton A JM. Risk of diabetes-related amputation in south Asians vs. Europeans in the UK.  Diabetic Med. 2002;  10 19 99-106
    PubMedGoogle Scholar
  • 24 Leggetter S Y, Chaturvedi N, Fuller J H, Edmonds M E. Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of Afro-Caribbeans and Europeans in the United Kingdom.  Arch Int Med. 2001;  162 73-78
    PubMedGoogle Scholar
  • 25 Resnick H E, Valsania P, Phillips C L. Diabetes mellitus and non-traumatic lower extremity in black and white Americans: the national health and nutrition examination survey epidemiology follow-up study 1971 - 1992.  Arch Int Med. 1999;  159 2470-2475
    CrossrefPubMedGoogle Scholar
  • 26 Most R S, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals.  Diabetes Care. 1983;  6 87-91
    CrossrefPubMedGoogle Scholar
  • 27 American Diabetes Association . Consensus development conference on diabetic wound care.  Diabetes Care. 1999;  22 1354-1360
    CrossrefPubMedGoogle Scholar
  • 28 Shearer A, Schuffham P, Gordois A, Ogleshy A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the US.  Diabetes Care. 2003;  26 2305-2310
    CrossrefPubMedGoogle Scholar
  • 29 Ragnarson-Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost utility analysis based on Markov model simulation.  Diabetologia. 2001;  44 2077-2087
    CrossrefPubMedGoogle Scholar
  • 30 Assal J P, Mehnert H, Tritschler H S, Sidorenko A, Keen H. ‘On your feet’ workshop on the diabetic foot.  J Diabet Comp. 2002;  16 183-194
    PubMedGoogle Scholar
  • 31 Ramsey S D, Newton K, Blough D. et al . Incidence outcomes and costs of foot ulcers in patients with diabetes.  Diabetes Care. 1999;  22 382-387
    CrossrefPubMedGoogle Scholar
  • 32 Diabetes care and research in Europe: the St Vincent Declaration. Diabet Med 1990 7: 360
    Google Scholar
  • 33 Larssen J. Lower extremity amputations in diabetic patients. Doctoral thesis. Lund University 1994
    Google Scholar
  • 34 Boulton A JM. The pathway to ulceration: aetiopathogenesis. In: Boulton AJM, Connor H, Cavanagh HPR (eds) The foot in diabetes, 3rd edition. Chichester; Wiley 2000: 19-31
    Google Scholar
  • 35 Reiber G E, Vileikyte L, Boyko E J. et al . Causal pathway for incident lower extremity ulcers in patients with diabetes from two settings.  Diabetes Care. 1999;  22 157-162
    CrossrefPubMedGoogle Scholar
  • 36 Boulton A JM, Hardisty C A, Betts R P. et al . Dynamic foot pressure and other studies as diagnostic and management aids for diabetic neuropathy.  Diabetes Care. 1983;  6 26-33
    PubMedGoogle Scholar
  • 37 Katoulis E C, Ebdon-Parry M, Hollis S. et al . Postural instability in diabetic patients at risk of foot ulceration.  Diabetic Med. 1997;  14 296-300
    CrossrefPubMedGoogle Scholar
  • 38 Katoulis E C, Ebdon-Parry M, Lanshammer H. et al . Gait abnormalities in diabetic neuropathy.  Diabetes Care. 1997;  20 1904-1907
    PubMedGoogle Scholar
  • 39 Vileikyte L, Rubin R R, Leventhal H. Psychological aspects of diabetic neuropathy and its late sequelae.  Diab Metab Res Rev. 2004;  20 [Suppl 1] S13-S18
    PubMedGoogle Scholar
  • 40 Young M J, Boulton A JM, MacLeod A F, Williams D RR, Sonksen P H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population.  Diabetologia. 1993;  36 150-154
    CrossrefPubMedGoogle Scholar
  • 41 Mayfield J A, Sugarman J R. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulcerations and amputations in persons with diabetes.  J Fam Pract. 2000;  49 [Suppl 11] S17-S29
    PubMedGoogle Scholar
  • 42 Booth J, Young M J. Differences in the performance of commercially available monofilaments.  Diabetes Care. 2000;  23 984-988
    PubMedGoogle Scholar
  • 43 Miranda-Palma B, Basu S, Mizel M S. et al . The monofilament as gold standard for foot ulcer risk screening: a reappraisal.  Diabetes. 2003;  53 [Suppl 1] A63
    PubMedGoogle Scholar
  • 44 Carrington A L, Shaw J E, Van Schie C HM, Abbott C A, Vileikyte L, Boulton A JM. Can motor nerve conduction velocity predict foot problems in diabetes over a six year outcome period?.  Diabetes Care. 2002;  25 2010-2015
    PubMedGoogle Scholar
  • 45 National Diabetes Advisory Board .The prevention and treatment of five complications of diabetes: a guide for primary care practitioners. Atlanta, GA; Centers for Disease Control HHS publ. no. 83-8392 1983
    Google Scholar
  • 46 Jude E B, Oyibo S O, Chalmers N, Boulton A JM. Peripheral arterial disease in diabetic and non-diabetic patients: a comparison of severity and outcome.  Diabetes Care. 2001;  24 1433-1437
    CrossrefPubMedGoogle Scholar
  • 47 Lavery L A, Armstrong D G, Vela S A. et al . Practical criteria for screening patients at high risk of diabetic foot ulceration.  Arch Int Med. 1998;  26 157-162
    PubMedGoogle Scholar
  • 48 Murray H J, Young M J, Boulton A JM. The relationship between callus formation, high pressures and neuropathy in diabetic foot ulceration.  Diabetic Med. 1996;  13 979-982
    CrossrefPubMedGoogle Scholar
  • 49 Valk G D, Kreigsman D M, Assendelf W J. Patient education for reducing diabetic foot ulceration: a systematic review.  Endocrinol Metab Clin N Amer. 2002;  31 633-658
    PubMedGoogle Scholar
  • 50 McCabe C J, Stevenson R C, Dolan A M. Evaluation of a diabetic foot screening and prevention programme.  Diabetic Med. 1998;  15 80-84
    CrossrefPubMedGoogle Scholar
  • 51 Vileikyte L. Psychological and behavioural issues in diabetic neuropathic foot ulceration. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes, 3rd edition. Chichester; Wiley 2000: 121-130
    Google Scholar
  • 52 Veves A, Boulton A JM. The optical pedobarograph.  Clin Podiatr Med Surg. 1993;  10 463-470
    PubMedGoogle Scholar
  • 53 Boulton A JM, Betts R P, Franks C I. et al . Abnormalities of foot pressure in early diabetic neuropathy.  Diabetic Med. 1987;  4 225-228
    PubMedGoogle Scholar
  • 54 Boulton A JM, Betts R P, Franks C I, Ward J D, Duckworth T. The natural history of foot pressure abnormalities in neuropathic diabetic subjects.  Diabetes Res. 1987;  5 73-77
    PubMedGoogle Scholar
  • 55 Newrick P G, Cochrane T, Betts R P, Ward J D, Boulton A JM. Reduced hyperaemic response under the neuropathic diabetic foot.  Diabetic Med. 1988;  5 570-573
    PubMedGoogle Scholar
  • 56 Young M J, Cavanagh P R, Thomas G. et al . The effect of callus removal on dynamic plantar foot pressures in diabetic patients.  Diabetic Med. 1992;  9 55-57
    CrossrefPubMedGoogle Scholar
  • 57 Veves A, Young M J, Murray H J, Boulton A JM. The risk of foot ulceration in diabetic patients with high foot pressures: a prospective study.  Diabetologia. 1993;  35 660-663
    PubMedGoogle Scholar
  • 58 Lavery L A, Armstrong D G, Wunderlich R P, R T redwell, Boulton A JM. Predictive value of foot pressure assessment when part of a population based diabetes disease management programme.  Diabetes Care. 2003;  26 1069-1073
    CrossrefPubMedGoogle Scholar
  • 59 Jeffcoate W J, Harding K G. Diabetic foot ulcers.  Lancet. 2003;  361 1545-1551
    CrossrefPubMedGoogle Scholar
  • 60 Jude E B, Blakytny R, Bulmer J, Boulton A JM, Ferguson M WJ. Transforming growth factor-beta 1, 2, 3 and receptor type 1 and 2 in diabetic foot ulcers.  Diabetic Med. 2002;  19 440-447
    CrossrefPubMedGoogle Scholar
  • 61 Lobmann R, Ambrosch A, Schultz G. et al . Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.  Diabetologia. 2002;  45 1011-1016
    CrossrefPubMedGoogle Scholar
  • 62 Boulton A JM, Armstrong D G. Studies in planter diabetic neuropathic ulcers; time for a paradigm shift?.  Diabetes Care. 2003;  26 2689-2690
    PubMedGoogle Scholar
  • 63 Brand P W. The Diabetic Foot. In: Ellenberg M, Rifkin H (eds) Diabetes mellitus: theory and practice, 3rd edn. New York; Med Exam Publishing 1983: 829-849
    Google Scholar
  • 64 Boulton A JM. Lawrence Lecture: the diabetic foot: neuropathic in aetiology?.  Diabetic Med. 1990;  7 852-858
    PubMedGoogle Scholar
  • 65 Armstrong D G, Nguyen H C, Lavery L A, van Schie C H, Boulton A JM, Harkless L BI. Off-Loading the diabetic foot wound: a randomized clinical trial.  Diabetes Care. 2001;  24 1019-1022
    PubMedGoogle Scholar
  • 66 Armstrong D G, Stacpoole-Shea S. TCC and removable cast walker. Mitigation of plantar heel pressure.  J Am Podiatr Med Assoc. 1999;  89 50-53
    PubMedGoogle Scholar
  • 67 Boulton A JM, Bowker J H, Gadia M. et al . Use of plaster casts in the management of diabetic neuropathic foot ulcers.  Diabetes Care. 1986;  9 149-152
    PubMedGoogle Scholar
  • 68 Mueller M J, Diamond J E, Sinacore D R. et al . Total contact casting in the treatment of diabetic plantar ulcers: controlled clinical trial.  Diabetes Care. 1989;  12 384-388
    CrossrefPubMedGoogle Scholar
  • 69 Mason J, O’Keefe C, Hutchinson A, McIntosh A, Young R, Booth A. A systematic review of foot ulcers in patients with type 2 diabetes mellitus treatment.  Diabetic Med. 1999;  16 889-909
    CrossrefPubMedGoogle Scholar
  • 70 Lavery L A, Vela S A, Lavery D C, Quebedeaux T L. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations: a comparison of treatments.  Diabetes Care. 1996;  19 818-821
    PubMedGoogle Scholar
  • 71 Baumhauer J F, Wervery R, McWilliams J, Harris G F, Shereff M J. A comparison study of plantar foot pressure in a standardized shoe, total contact cast prefabricated pneumatic walking brace.  Foot Ankle Int. 1997;  18 26-33
    PubMedGoogle Scholar
  • 72 Armstrong D G, Lavery L A, Kimbriel H R, Nixon B P, Boulton A JM. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to pressure offloading regimen.  Diabetes Care. 2003;  26 2595-2597
    CrossrefPubMedGoogle Scholar
  • 73 Veves A, Sheehan P, Pham H T. A randomized control trial of Promogran vs standard treatment in the management of diabetic foot ulcers.  Arch Surg. 2002;  137 822-827
    CrossrefPubMedGoogle Scholar
  • 74 Ha Van G, Siney H, Hartmann-Heurtier A, Jacqueminet S, Greau F, Grimaldi A. Nonremovable, windowed, fibreglass cast boot in the treatment of diabetic planter ulcers: efficacy, safety and compliance.  Diabetes Care. 2003;  26 2848-2852
    CrossrefPubMedGoogle Scholar
  • 75 Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers (Cochrane Review).  In: The Cochrane Library. Issue 3. Chichester; John Wiley and Sons Ltd 2002
    Google Scholar
  • 76 Armstrong D G, Short B, Espensen E H, Abu-Ramman P L, Nixon B P, Boulton A JM. Technique for fabrication of an ‘instant total contact cast’ for treatment of neuropathic diabetic foot ulcers.  J Am Pod Med Assoc. 2002;  92 405-408
    PubMedGoogle Scholar
  • 77 Katz I, Harlan A, Miranda-Palma B. et al . A randomised trial of two irremovable offloading devices in the management of plantar neuropathic diabetic foot ulcers.  Diabetes Care. 2005;  28 555-559
    CrossrefPubMedGoogle Scholar
  • 78 Piaggesi A, Viacava P, Rizzo L. et al . Semi-quantitative analysis of the histopathological features of the neuropathic foot ulcer-effects of pressure relief.  Diabetes Care. 2003;  26 3123-3128
    PubMedGoogle Scholar
  • 79 Knowles E A, Armstrong D G, Hayat S A, Boulton A JM. et al . Offloading diabetic foot wounds using the scotchcast boot: a retrospective study.  Ostomy Wound Manage. 2002;  48 50-53
    PubMedGoogle Scholar
  • 80 Armstrong D G, Lavery L A, Wu S, Boulton A J. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial.  Diabetes Care. 2005;  28 551-554
    PubMedGoogle Scholar

Dr. H. M. Rathur MRCP

Manchester Royal Infirmary

Oxford Road · Manchester M13 9WL · UK ·

Phone: + 44(161)2764452

Fax: + 44(161)2744740

Email: harisrathur@hotmail.com

      >